ghk-cu dosage guidelines KLOW Peptide & Protocol Guide GHK-Cu Dosage Chart: 50 mg

A 2025 paper published in BioImpacts confirmed topical GHK is increasingly being studied as a clinical anti-aging compound with hair restoration applications and that injectable forms are now entering clinical interest following the FDA's April 2026 decision to remove GHK-Cu from the Category 2 restricted list

AOD-9604 is available as an injectable, sublingual troche, and topical cream

Belimumab acts by blocking B lymphocyte stimulator a protein found in very high levels in lupus patients that allows B cells to live longer

BPC-157

Early but promising Creatine monohydrate is still the most researched form

Some peptides benefit from cycling periods of use followed by planned breaks